Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Weinstock-Guttman

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Drugs|April 25, 2000
What is new in the treatment of multiple sclerosis?B Weinstock-Guttman, L D Jacobs
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Drug Safety|February 1, 1996
Newer versus older treatments for relapsing-remitting multiple sclerosisB Weinstock-Guttman, J A Cohen
Neurology|May 15, 2009
Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamideE A Yeh, B Weinstock-Guttman
Advances in Therapy|March 12, 2011
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosisE Ann Yeh, B Weinstock-Guttman
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2011
Regarding CCSVI and MS: a never-ending story or a new chapter?R Zivadinov, F Salvi, B Weinstock-Guttman
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2011
Regarding CCSVI: is blinding the key?P Zamboni, B Weinstock-Guttman, R Zivadinov
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Neurologic complications of immunosuppressive and anti-inflammatory therapy for rheumatic diseasesB Weinstock-Guttman, D Nair, J A Cohen
Journal of Computer Assisted Tomography|July 1, 1995
Unusual long-standing Gd-DTPA enhancement in a chronic progressive myelopathyB Weinstock-Guttman, J S Ross, R M Ransohoff
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosisN Garg, B Weinstock-Guttman, K Bhasi, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Drugs|April 25, 2000
What is new in the treatment of multiple sclerosis?B Weinstock-Guttman, L D Jacobs
CNS Drugs|January 23, 2013
Prescribing recommendations for interferon-Beta in multiple sclerosisB Weinstock-Guttman, R A Rudick
Drug Safety|February 1, 1996
Newer versus older treatments for relapsing-remitting multiple sclerosisB Weinstock-Guttman, J A Cohen
Neurology|May 15, 2009
Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamideE A Yeh, B Weinstock-Guttman
Advances in Therapy|March 12, 2011
Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosisE Ann Yeh, B Weinstock-Guttman
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2011
Regarding CCSVI and MS: a never-ending story or a new chapter?R Zivadinov, F Salvi, B Weinstock-Guttman
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 20, 2011
Regarding CCSVI: is blinding the key?P Zamboni, B Weinstock-Guttman, R Zivadinov
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Neurologic complications of immunosuppressive and anti-inflammatory therapy for rheumatic diseasesB Weinstock-Guttman, D Nair, J A Cohen
Journal of Computer Assisted Tomography|July 1, 1995
Unusual long-standing Gd-DTPA enhancement in a chronic progressive myelopathyB Weinstock-Guttman, J S Ross, R M Ransohoff
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 1, 2007
An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosisN Garg, B Weinstock-Guttman, K Bhasi, et al.
Pageof 11